Skip to main content

Child with Fever — Bacterial Infections and Possible Empiric Antibiotic Choices — Clinical Pathway: All Settings

Fever Clinical Pathway — All Settings

Infection Most Common Causative Organism(s) Empiric Antibiotic Choices
Periorbital Cellulitis
  • Staphylococcus aureus (MSSA and MRSA)
  • Group A streptococcus
Periorbital Cellulitis Antibiotic Recommendations
Orbital Cellulitis
  • S. aureus (MSSA and MRSA)
  • Group A streptococcus
  • Anginosus group streptococci (S. anginosus, constellatus, and intermedius)
  • S. pneumoniae
  • Haemophilus influenzae
  • Anaerobes
Orbital Cellulitis Antibiotic Recommendations
Lymphadenitis
  • Acute bacterial lymphadenitis:
    • S. aureus (including MSSA and MRSA)
    • Group A streptococcus
    • Oral anaerobes, if concern for poor dentition/odontogenic source
  • Note: bilateral disease is most often due to viral infections (e.g., Epstein-Barr virus)
  • Rare causes generally associated with subacute presentations:
    • Bartonella henselae
    • Nontuberculous mycobacteria
  • Acute bacterial lymphadenitis:
    • Cephalexin
    • or
    • Amoxicillin/clavulanate
    • or
    • Clindamycin if history of MRSA or MRSA risk factors
      (e.g., family with MRSA) or allergy to first-line β-lactam – assess need for alternative
    • Antibiotic treatment is not generally recommended for immunocompetent hosts with lymphadenitis caused by B. henselae because it does not reduce duration of illness
    • Discuss with ID and refer to general surgery clinic if concern for nontuberculous mycobacteria
Peritonsillar Abscess
  • Group A streptococcus
  • Oral anaerobes (Fusobacteria, Prevotella, Veillonella species)
  • S. aureus (including MSSA and MRSA)
Peritonsillar Abscess Antibiotic Recommendations
Retropharyngeal Abscess
  • S. aureus (including MSSA and MRSA)
  • Group A streptococcus
  • Respiratory anaerobes
  • S. anginosis group
Neck Space Infection Antibiotic Recommendations
Dental Abscess Oral anaerobes (e.g., Fusobacteria, Prevotella, Veillonella species) Dental Abscess Antibiotic Recommendations
Pharyngitis, Exudative
  • Most pharyngitis is caused by viral infections (e.g., Epstein-Barr virus, adenovirus)
  • Bacterial etiologies:
    • Group A streptococcus
    • If sexually active:
      • Neisseria gonorrhea
Pharyngitis Antibiotic Recommendations
Acute Bacterial Sinusitis
  • S. pneumoniae
  • H. influenzae
  • M. catarrhalis
  • Amoxicillin or amoxicillin/clavulanate
  • Penicillin allergy:
    • Cefdinir or cefpodoxime (preferred) or
      levofloxacin (alternative)
Otitis Media without Perforation
  • S. pneumoniae
  • H. influenzae
  • M. catarrhalis
Acute Otitis Media Pathway Antibiotic Recommendations
Mastoiditis
  • Acute mastoiditis:
    • S. pneumoniae
    • Group A streptococcus
    • S. aureus (including MSSA and MRSA)
    • H. influenzae
    • Pseudomonas aeruginosa (rare)
  • Additional considerations for chronic mastoiditis:
    • Pseudomonas aeruginosa
    • Upper respiratory anaerobes
  • Acute mastoiditis:
  • Chronic mastoiditis:
    • Consult ID
Cellulitis, Non-purulent Group A streptococcus Cellulitis/Abscess Pathway Antibiotic Recommendations
Purulent Cellulitis/Abscess
  • S. aureus (including MSSA and MRSA)
  • Group A streptococcus
Pyomyositis
  • S. aureus (including MSSA and MRSA)
  • Group A streptococcus (rare)
  • E. coli, K. pneumoniae (very rare)
  • Non-severe:
    • No MRSA risk factors: cefazolin
    • Personal or family history of MRSA, IV drug use: clindamycin (if known history of clindamycin-resistant MRSA, select antibiotic based on prior susceptibilities)
  • Severe, rapidly progressing, ill:
    • Contact ID to discuss empiric antibiotics
    • Vancomycin + ceftriaxone (see also Sepsis Pathway)
Necrotizing Fasciitis
  • Group A streptococcus
  • S. aureus (including MSSA and MRSA)
  • Clostridium spp (e.g., perfringens, septicum)
  • Aeromonas hydrophila
  • Vibrio spp
  • K. pneumoniae, E. coli (rare)
  • Emergent surgical debridement
  • Contact ID to discuss empiric antibiotics, which may vary depending on clinical scenario
    • Vancomycin + piperacillin-tazobactam + clindamycin
Septic Arthritis
  • S. aureus (including MSSA and MRSA)
  • Group A streptococcus
  • Kingella kingae
  • Borrelia burgdorferi
  • Rare causes of septic arthritis:
    • Neisseria gonorrhoeae (sexually active individuals)
    • Salmonella (children and adolescents with sickle cell disease)
Osteomyelitis
  • S. aureus (including MSSA and MRSA)
  • Group A streptococcus
  • Kingella kingae
  • Rare causes of osteomyelitis:
    • S. pneumoniae
    • Salmonella in (children and adolescents with sickle cell disease)
Osteomyelitis Pathway Antibiotic Recommendations
Community-acquired Pneumonia
  • Viral infections are the most common cause of community-acquired pneumonia
  • Bacterial etiologies:
    • S. pneumoniae
    • H. influenzae
    • S. aureus (including MSSA and MRSA)
    • Group A streptococcus
Urinary Tract Infection (Cystitis, Pyelonephritis)
  • Enterobacterales (e.g., E. coli, K. pneumoniae)
  • P. aeruginosa (child with underlying genitourinary disease)
  • Enterococcus spp.
Meningitis/Encephalitis
  • Infants/children > 56 days
  • Bacterial disease:
    • S. pneumoniae
    • N. meningitidis
    • H. Influenzae
  • Other etiologies:
    • Herpes simplex (HSV)
    • Enterovirus (summer months)
    • Borrelia burgdorferi
    • Tuberculosis (rare)
Recommended Empiric Antibiotics for Acute Bacterial Meningitis
Ventriculitis/ Ventricular Shunt Infection
  • Coagulase-negative Staphylococcus spp
  • S. aureus (including MSSA and MRSA)
  • Enterobacterales (E. coli, Klebsiella spp, Enterobacter spp)
  • P. aeruginosa
  • Cutibacterium (Propionibacterium) acnes
Recommended Empiric Antibiotics for Suspected VP Shunt Infections
Intraabdominal Infection (excluding pelvic inflammatory disease)
  • Enterobacterales (e.g., E. coli, K. pneumoniae)
  • Lower intestinal anaerobes (e.g., Bacteroides fragilis)
  • Enterococcus spp.
  • P. aeruginosa (rare)
  • Streptococcus pneumoniae (spontaneous bacterial peritonitis)
  • Antibiotic choice depends on the type of intra-abdominal infection and comorbid medical conditions; the following serves as a general guide:
    • Appendicitis Pathway
    • Non-appendicitis intraabdominal infection:
      • Community onset/non-severe
      • Hospital onset/immunocompromised/severe:
    • Consider infectious disease consultation

CHOP Formulary for complete drug information.

 

Jump back to top